Table of Contents

2019-2024 Global Equine Pharmaceuticals and Supplements Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Equine Pharmaceuticals and Supplements Consumption 2014-2024
2.1.2 Equine Pharmaceuticals and Supplements Consumption CAGR by Region
2.2 Equine Pharmaceuticals and Supplements Segment by Type
2.2.1 Pharmaceuticals
2.2.2 Supplements
2.3 Equine Pharmaceuticals and Supplements Consumption by Type
2.3.1 Global Equine Pharmaceuticals and Supplements Consumption Market Share by Type (2014-2019)
2.3.2 Global Equine Pharmaceuticals and Supplements Revenue and Market Share by Type (2014-2019)
2.3.3 Global Equine Pharmaceuticals and Supplements Sale Price by Type (2014-2019)
2.4 Equine Pharmaceuticals and Supplements Segment by Application
2.4.1 Thoroughbred Horse
2.4.2 Other Types of Horses
2.5 Equine Pharmaceuticals and Supplements Consumption by Application
2.5.1 Global Equine Pharmaceuticals and Supplements Consumption Market Share by Application (2014-2019)
2.5.2 Global Equine Pharmaceuticals and Supplements Value and Market Share by Application (2014-2019)
2.5.3 Global Equine Pharmaceuticals and Supplements Sale Price by Application (2014-2019)

3 Global Equine Pharmaceuticals and Supplements by Players
3.1 Global Equine Pharmaceuticals and Supplements Sales Market Share by Players
3.1.1 Global Equine Pharmaceuticals and Supplements Sales by Players (2017-2019)
3.1.2 Global Equine Pharmaceuticals and Supplements Sales Market Share by Players (2017-2019)
3.2 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Players
3.2.1 Global Equine Pharmaceuticals and Supplements Revenue by Players (2017-2019)
3.2.2 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Players (2017-2019)
3.3 Global Equine Pharmaceuticals and Supplements Sale Price by Players
3.4 Global Equine Pharmaceuticals and Supplements Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Equine Pharmaceuticals and Supplements Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Equine Pharmaceuticals and Supplements Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers and Acquisitions, Expansion

4 Equine Pharmaceuticals and Supplements by Regions
4.1 Equine Pharmaceuticals and Supplements by Regions
4.1.1 Global Equine Pharmaceuticals and Supplements Consumption by Regions
4.1.2 Global Equine Pharmaceuticals and Supplements Value by Regions
4.2 Americas Equine Pharmaceuticals and Supplements Consumption Growth
4.3 APAC Equine Pharmaceuticals and Supplements Consumption Growth
4.4 Europe Equine Pharmaceuticals and Supplements Consumption Growth
4.5 Middle East and Africa Equine Pharmaceuticals and Supplements Consumption Growth

5 Americas
5.1 Americas Equine Pharmaceuticals and Supplements Consumption by Countries
5.1.1 Americas Equine Pharmaceuticals and Supplements Consumption by Countries (2014-2019)
5.1.2 Americas Equine Pharmaceuticals and Supplements Value by Countries (2014-2019)
5.2 Americas Equine Pharmaceuticals and Supplements Consumption by Type
5.3 Americas Equine Pharmaceuticals and Supplements Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Equine Pharmaceuticals and Supplements Consumption by Countries
6.1.1 APAC Equine Pharmaceuticals and Supplements Consumption by Countries (2014-2019)
6.1.2 APAC Equine Pharmaceuticals and Supplements Value by Countries (2014-2019)
6.2 APAC Equine Pharmaceuticals and Supplements Consumption by Type
6.3 APAC Equine Pharmaceuticals and Supplements Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Equine Pharmaceuticals and Supplements by Countries
7.1.1 Europe Equine Pharmaceuticals and Supplements Consumption by Countries (2014-2019)
7.1.2 Europe Equine Pharmaceuticals and Supplements Value by Countries (2014-2019)
7.2 Europe Equine Pharmaceuticals and Supplements Consumption by Type
7.3 Europe Equine Pharmaceuticals and Supplements Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East and Africa
8.1 Middle East and Africa Equine Pharmaceuticals and Supplements by Countries
8.1.1 Middle East and Africa Equine Pharmaceuticals and Supplements Consumption by Countries (2014-2019)
8.1.2 Middle East and Africa Equine Pharmaceuticals and Supplements Value by Countries (2014-2019)
8.2 Middle East and Africa Equine Pharmaceuticals and Supplements Consumption by Type
8.3 Middle East and Africa Equine Pharmaceuticals and Supplements Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Equine Pharmaceuticals and Supplements Distributors
10.3 Equine Pharmaceuticals and Supplements Customer

11 Global Equine Pharmaceuticals and Supplements Market Forecast
11.1 Global Equine Pharmaceuticals and Supplements Consumption Forecast (2019-2024)
11.2 Global Equine Pharmaceuticals and Supplements Forecast by Regions
11.2.1 Global Equine Pharmaceuticals and Supplements Forecast by Regions (2019-2024)
11.2.2 Global Equine Pharmaceuticals and Supplements Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East and Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East and Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Equine Pharmaceuticals and Supplements Forecast by Type
11.8 Global Equine Pharmaceuticals and Supplements Forecast by Application

12 Key Players Analysis
12.1 Boehringer Ingelheim
12.1.1 Company Details
12.1.2 Equine Pharmaceuticals and Supplements Product Offered
12.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Boehringer Ingelheim News
12.2 Merck Animal Health
12.2.1 Company Details
12.2.2 Equine Pharmaceuticals and Supplements Product Offered
12.2.3 Merck Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Merck Animal Health News
12.3 Zoetis
12.3.1 Company Details
12.3.2 Equine Pharmaceuticals and Supplements Product Offered
12.3.3 Zoetis Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Zoetis News
12.4 Bayer Animal Health
12.4.1 Company Details
12.4.2 Equine Pharmaceuticals and Supplements Product Offered
12.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Bayer Animal Health News
12.5 Elanco Animal Health
12.5.1 Company Details
12.5.2 Equine Pharmaceuticals and Supplements Product Offered
12.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Elanco Animal Health News
12.6 Dechra Veterinary Products
12.6.1 Company Details
12.6.2 Equine Pharmaceuticals and Supplements Product Offered
12.6.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Dechra Veterinary Products News
12.7 CEVA
12.7.1 Company Details
12.7.2 Equine Pharmaceuticals and Supplements Product Offered
12.7.3 CEVA Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 CEVA News
12.8 Virbac
12.8.1 Company Details
12.8.2 Equine Pharmaceuticals and Supplements Product Offered
12.8.3 Virbac Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Virbac News
12.9 Norbrook Equine
12.9.1 Company Details
12.9.2 Equine Pharmaceuticals and Supplements Product Offered
12.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Norbrook Equine News
12.10 Kyoritsu Seiyaku
12.10.1 Company Details
12.10.2 Equine Pharmaceuticals and Supplements Product Offered
12.10.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Kyoritsu Seiyaku News
12.11 Vetoquinol
12.12 Protexin Healthcare
12.13 Audevard
12.14 Ouro Fino Saude

13 Research Findings and Conclusion